Sotera Health (SHC) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
1.1B
Gross Profit
602.3M
54.73%
Operating Income
297.6M
27.05%
Net Income
44.4M
4.03%
EPS (Diluted)
$0.16
Balance Sheet Metrics
Total Assets
3.1B
Total Liabilities
2.7B
Shareholders Equity
404.9M
Debt to Equity
6.59
Cash Flow Metrics
Operating Cash Flow
233.2M
Free Cash Flow
45.1M
Revenue & Profitability Trend
Sotera Health Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 1.0B | 1.0B | 931.5M | 818.2M |
| Cost of Goods Sold | 498.1M | 472.1M | 446.7M | 412.8M | 374.6M |
| Gross Profit | 602.3M | 577.2M | 557.0M | 518.7M | 443.6M |
| Operating Expenses | 242.6M | 236.7M | 245.7M | 198.2M | 178.5M |
| Operating Income | 297.6M | 276.7M | 248.4M | 256.7M | 206.0M |
| Pre-tax Income | 113.9M | 106.0M | -243.1M | 175.7M | -38.9M |
| Income Tax | 69.5M | 54.7M | -9.5M | 58.6M | -1.4M |
| Net Income | 44.4M | 51.4M | -233.6M | 117.1M | -37.5M |
| EPS (Diluted) | $0.16 | $0.18 | -$0.83 | $0.41 | -$0.16 |
Income Statement Trend
Sotera Health Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 526.0M | 557.2M | 645.0M | 346.0M | 315.0M |
| Non-Current Assets | 2.5B | 2.6B | 2.5B | 2.4B | 2.4B |
| Total Assets | 3.1B | 3.1B | 3.1B | 2.8B | 2.8B |
| Liabilities | |||||
| Current Liabilities | 191.0M | 230.7M | 791.6M | 161.2M | 140.6M |
| Non-Current Liabilities | 2.5B | 2.5B | 2.0B | 2.0B | 2.2B |
| Total Liabilities | 2.7B | 2.7B | 2.8B | 2.2B | 2.3B |
| Equity | |||||
| Total Shareholders Equity | 404.9M | 443.7M | 350.2M | 586.1M | 454.6M |
Balance Sheet Composition
Sotera Health Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 44.4M | 51.4M | -233.6M | 117.1M | -37.5M |
| Operating Cash Flow | 233.2M | -155.7M | 248.8M | 259.7M | 86.7M |
| Investing Activities | |||||
| Capital Expenditures | -179.1M | -215.0M | -182.4M | -102.2M | -53.5M |
| Investing Cash Flow | -179.0M | -214.9M | -181.9M | -159.8M | -158.7M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | 0 | 0 |
| Financing Cash Flow | -2.3B | 63.5M | 197.8M | -217.3M | -953.9M |
| Free Cash Flow | 45.1M | -362.7M | 95.6M | 179.4M | 67.1M |
Cash Flow Trend
Sotera Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
124.89
Forward P/E
13.88
Price to Book
7.70
Price to Sales
2.88
PEG Ratio
13.88
Profitability Ratios
Profit Margin
2.24%
Operating Margin
27.86%
Return on Equity
5.88%
Return on Assets
7.01%
Financial Health
Current Ratio
2.46
Debt to Equity
566.88
Beta
1.87
Per Share Data
EPS (TTM)
$0.09
Book Value per Share
$1.46
Revenue per Share
$3.91
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| shc | 3.2B | 124.89 | 7.70 | 5.88% | 2.24% | 566.88 |
| Thermo Fisher | 152.5B | 23.69 | 3.09 | 13.70% | 15.19% | 69.23 |
| Danaher | 140.5B | 37.98 | 2.76 | 7.22% | 15.81% | 34.56 |
| Qiagen N.V | 10.1B | 108.63 | 2.97 | 2.67% | 4.68% | 41.36 |
| Medpace Holdings | 8.9B | 23.58 | 15.48 | 65.83% | 19.31% | 25.33 |
| Charles River | 7.2B | 681.33 | 2.27 | -0.67% | -0.49% | 92.21 |
Financial data is updated regularly. All figures are in the company's reporting currency.